Literature DB >> 11222779

Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay.

G K Kovvali1, B Mehta, C B Epstein, S G Lutzker.   

Abstract

Missense mutations within the central DNA binding region of p53 are the most prevalent mutations found in human cancer. Numerous studies indicate that 'hot-spot' p53 mutants (which comprise approximately 30% of human p53 gene mutations) are largely devoid of transcriptional activity. However, a growing body of evidence indicates that some non-hot-spot p53 mutants retain some degree of transcriptional activity in vivo, particularly against strong p53 binding sites. We have modified a previously described yeast-based p53 functional assay to readily identify such partial loss of function p53 mutants. We demonstrate the utility of this modified p53 functional assay using a diverse panel of p53 mutants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222779      PMCID: PMC29741          DOI: 10.1093/nar/29.5.e28

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  Pharmacological rescue of mutant p53 conformation and function.

Authors:  B A Foster; H A Coffey; M J Morin; F Rastinejad
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

2.  A transcriptionally active DNA-binding site for human p53 protein complexes.

Authors:  W D Funk; D T Pak; R H Karas; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 3.  IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.

Authors:  T Hernandez-Boussard; P Rodriguez-Tome; R Montesano; P Hainaut
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

4.  Identification of p53 as a sequence-specific DNA-binding protein.

Authors:  S E Kern; K W Kinzler; A Bruskin; D Jarosz; P Friedman; C Prives; B Vogelstein
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

Review 5.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

6.  Screening patients for heterozygous p53 mutations using a functional assay in yeast.

Authors:  C Ishioka; T Frebourg; Y X Yan; M Vidal; S H Friend; S Schmidt; R Iggo
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

7.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

8.  A simple p53 functional assay for screening cell lines, blood, and tumors.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; P Chappuis; A P Sappino; I M Limacher; L Bron; J Benhattar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance.

Authors:  J D Boeke; F LaCroute; G R Fink
Journal:  Mol Gen Genet       Date:  1984

10.  Identification and molecular analysis of a third Aspergillus nidulans alcohol dehydrogenase gene.

Authors:  G L McKnight; H Kato; A Upshall; M D Parker; G Saari; P J O'Hara
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more
  1 in total

1.  The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.

Authors:  Jodi A McKenzie; Rina M Mbofung; Shruti Malu; Min Zhang; Emily Ashkin; Seram Devi; Leila Williams; Trang Tieu; Weiyi Peng; Sunila Pradeep; Chunyu Xu; Soraya Zorro Manrique; Chengwen Liu; Lu Huang; Yuan Chen; Marie-Andree Forget; Cara Haymaker; Chantale Bernatchez; Nikunj Satani; Florian Muller; Jason Roszik; Ashish Kalra; Timothy Heffernan; Anil Sood; Jianhua Hu; Rodabe Amaria; R Eric Davis; Patrick Hwu
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.